Partnering for Therapeutics Discovery

ArticleinClinical Pharmacology &#38 Therapeutics 93(1) · November 2012with3 Reads
Impact Factor: 7.90 · DOI: 10.1038/clpt.2012.188 · Source: PubMed


    The Discovering New Therapeutic Uses for Existing Molecules pilot program, led by the National Center for Advancing Translational Sciences (NCATS), uses innovative strategies such as crowdsourcing and template agreements to match ­researchers with a selection of molecular compounds from industry in order to test ideas for new therapeutic uses. Awardees will have the opportunity to validate and de-risk the targets of already well-developed compounds with the ultimate goal of identifying promising new treatments for patients.Clinical Pharmacology & Therapeutics (2013); 93 1, 24-25. doi:10.1038/clpt.2012.188